These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 6406653)

  • 21. Corporate wellness programs can be cost-effective.
    Dionne ED
    Natl Saf News; 1984 Mar; 129(3):70-2. PubMed ID: 10310479
    [No Abstract]   [Full Text] [Related]  

  • 22. Seasonal protection through voluntary programs.
    Parmet AJ
    Occup Health Saf; 1981 Nov; 50(11):27-8, 30. PubMed ID: 6796921
    [No Abstract]   [Full Text] [Related]  

  • 23. Core and comprehensive health care services: 4. Economic issues.
    Wyman M; Feeley J; Brimacombe G; Doucette K
    CMAJ; 1995 May; 152(10):1601-4. PubMed ID: 7743446
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevention: is there value for corporate purchasers?
    Kerr VE
    Am J Health Promot; 2001; 15(5):360-1. PubMed ID: 11502019
    [No Abstract]   [Full Text] [Related]  

  • 25. [Efficiency assessment of investment in workers' health--economic issues].
    Rydlewska-Liszkowska I; Dawydzik LT
    Med Pr; 2002; 53(4):319-27. PubMed ID: 12474412
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Economic benefit of chemical dependency treatment to employers.
    Jordan N; Grissom G; Alonzo G; Dietzen L; Sangsland S
    J Subst Abuse Treat; 2008 Apr; 34(3):311-9. PubMed ID: 17614238
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Health and safety economics: limitations of economic appraisal of occupational health services activities in Poland.
    Rydlewska-Liszkowska I
    Int J Occup Med Environ Health; 2002; 15(2):193-7. PubMed ID: 12216778
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Outcome studies in industry: cost-effectiveness of cumulative trauma disorder prevention.
    Mitchell CS
    Am J Ind Med; 1996 Jun; 29(6):689-96. PubMed ID: 8773729
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Health economy: evaluating the costs and benefits of occupational health programs.
    Watts NT
    Scand J Rehabil Med Suppl; 1995; 32():101-6. PubMed ID: 7784831
    [No Abstract]   [Full Text] [Related]  

  • 30. The challenges of economic evaluations of remote technical health interventions.
    Kennedy CA
    Clin Invest Med; 2005 Apr; 28(2):71-4. PubMed ID: 15909483
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The business planning process applied to an in-house corporate occupational medicine unit.
    Anstadt GW; Lester DL; Powell BH; Mitchell JW; Tunaitis EM
    J Occup Med; 1991 Mar; 33(3):354-7. PubMed ID: 2030436
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A critical evaluation of the Utah Power and Light Company's Substance Abuse Management Program: absenteeism, accidents and costs.
    Crouch DJ; Webb DO; Peterson LV; Buller PF; Rollins DE
    NIDA Res Monogr; 1989; 91():169-93. PubMed ID: 2509923
    [No Abstract]   [Full Text] [Related]  

  • 33. Cost-effectiveness analysis in oncology.
    Evans WK
    Praxis (Bern 1994); 2000 Mar; 89(12):492-6. PubMed ID: 10771589
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Investments in alcohol treatment can boost employers' bottom lines.
    Raskin E; Williams L
    Issue Brief (George Wash Univ Med Cent Ensuring Solut Alcohol Probl); 2003 Jun; (5):1-2. PubMed ID: 12852423
    [No Abstract]   [Full Text] [Related]  

  • 35. A research agenda for economic evaluation of substance abuse services.
    French MT; Drummond M
    J Subst Abuse Treat; 2005 Sep; 29(2):125-37. PubMed ID: 16135341
    [TBL] [Abstract][Full Text] [Related]  

  • 36. An assessment of occupational health care in the Netherlands (1996-2005).
    De Valk MM; Oostrom C; Schrijvers AJ
    Occup Med (Lond); 2006 Oct; 56(7):475-9. PubMed ID: 16896055
    [TBL] [Abstract][Full Text] [Related]  

  • 37. With cost-effectiveness analysis firms can compare health programs.
    Chenoweth D
    Occup Health Saf; 1987 Mar; 56(3):31-2. PubMed ID: 3104846
    [No Abstract]   [Full Text] [Related]  

  • 38. Procedures and methods of benefit assessments for medicines in Germany.
    Bekkering GE; Kleijnen J
    Eur J Health Econ; 2008 Nov; 9 Suppl 1():5-29. PubMed ID: 18987905
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Analysis of costs involved in activities of regional occupational health centers].
    Rydlewska-Liszkowska I; Jugo B
    Med Pr; 2000; 51(4):373-82. PubMed ID: 11059411
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Counting the cost of sickness.
    Hayne C
    Nurs Times; 1984 Aug 15-21; 80(33):50-1. PubMed ID: 6236429
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.